Navigation Links
University of Detroit Mercy School of Dentistry Moves to Larger Facility on New Corktown Campus
Date:1/14/2008

$25.5 Million Investment in Detroit - Opens Thursday

DETROIT, Jan. 14 /PRNewswire/ -- On Thursday, January 17, at 10 a.m., University of Detroit Mercy will be opening a new School of Dentistry and Clinic, part of the institution's $80 million investment in giving back to the City of Detroit. The new wireless facility is one of the largest dental school and clinics in the country.

Over 261,000 square feet, the School's new location is more than twice the size of its prior home, featuring a high-tech simulation lab with 100 stations, 190 patient operatories and dedicated areas for pediatric, endodontic, and orthodontic dentistry. Cost for dental care is approximately half the cost of private dentistry. With more than 85,000 patient visits each year, the new location will give UDM the opportunity to serve more patients and accept additional students to the program.

"At UDM, it is crucial that we aspire to develop graduates who lead and serve in their community, and exciting new projects such as this will allow us to continue to prepare future dental professionals for our community," said UDM President Gerard L. Stockhausen, S.J.

"The urban context at the University of Detroit Mercy matters," he added. "We choose to be committed to this city as our sponsors, the Jesuits and Sisters of Mercy, have from the University's earliest beginnings, nearly 130 years ago. It is the University's place to be present, and to learn from our actions and our service in our city."

Located on UDM's new Corktown Campus at 2700 Martin Luther King Jr. Boulevard, the Dental School and Clinic is one block east of I-96 Jeffries and just minutes from I-94, I-75 and the Lodge Freeways. The Campus has secured, lighted parking for 860 cars.

The UDM School of Dentistry is one of two in the State of Michigan. One- third of all dentists in Michigan have graduated from the University's Dental School and nearly half of the graduating class remains
'/>"/>

SOURCE University of Detroit Mercy
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. 2 Hebrew University scientists awarded Wolf Prizes
2. NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired
3. Rockefeller Universitys Center for Clinical and Translational Science funds pilot studies
4. Presidential Candidate and Former Arkansas Governor Mike Huckabee to Be Keynote Speaker for Hope International Universitys Celebrate Hope Dinner at Disneyland(R) Hotel
5. University Hospitals Chief Executive Officer Extends Contract
6. Delta Dental of Illinois Announces Major Gift to University of Illinois at Chicago College of Dentistry
7. Royalty Pharma Acquires a Portion of Northwestern Universitys Royalty Interest in Lyrica(R) for $700 Million
8. Study investigates cannabis use among university students
9. Boston University Medical Center researcher honored
10. Brooks and the University of Florida Reach Research Agreement
11. University of British Columbia Research Shows Health Benefits of GameBike (TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Newswire-USNewswire/ -- New research at West Virg... spitless tobacco product aimed at young adults is...RJ Reynolds, Camel Snus - touted as a socially acc...singly high levels of nicotine. , , "Camel ...products," said Bruce Adkins of the state Division...
(Date:11/21/2008)...swire-USNewswire/ -- U.S. News & World Report ...NCQA) ranked BlueChoice(R) HealthPlan of South Car...ans(TM), published in U.S. News & World Report...l ranking ranks the nation,s best health plans bas...QA accreditation scores. NCQA and U.S. News & ...
(Date:11/21/2008)...swire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NY...overwhelmingly approved the proposals submitted to...Pharmaceuticals Industries Ltd. (Nasdaq: TEVA )....elming support of the transaction by the Barr shar...nd CEO. "We are pleased with the progress that we ...
(Date:11/21/2008)...y diseaseits cause remains a mysteryswept into Ath...citizens, soldiers and refugees of the war then ra...with corpses, social order broke down. Over the ne...ens lost a third of its population. It lost the wa...f the end of the Golden Age of Greece. , The Pl...
Breaking Medicine News(10 mins):Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...ons running at double the number of what they were...e reached an all time high//.Deaths due to alcohol...ast five years, Government sources revealed. Off...compiled for the NHS, found that 35,400 people wer...
...aving several older brothers increases the chances...t adds //weight to the idea of a biological basis ...rock University in St Catharines, Canada said, "It...and other studies suggest that there is probably a...
...eported by residents living near the former VA Tec... the massive fire which ripped// through this indu...mon health problems such as eczema, asthma, psoria...r environment and health experts have found no evi...
...re found to be associated with reduced length of a... community-acquired //pneumonia (CAP) – Study find...ed to be a good indicator for early discontinuance...red with other parameters. The study, which is th...
Other Medicine News:Health News:Alcohol-Related Illnesses On The Rise 2Health News:No Clue to Cause of Mystery Illnesses 2Health News:Procalcitonin-Guided Antibiotic Therapy Proved Effective in CAP Cure 2Health News:Procalcitonin-Guided Antibiotic Therapy Proved Effective in CAP Cure 3
(Date:11/20/2008)... New Jersey American Water has lifted the precaut...he following municipalities in Middlesex, Somerset..., , , Dunellen , Edison , ...lainfield , , , , Somerset County ,...er , Green Brook , Hillsborough , ...
(Date:11/20/2008)...ewswire-FirstCall/ -- Arpida (SWX:,ARPN) announce...mittee of the,U.S. Food and Drug Administration (...travenous iclaprim, an antibiotic currently in dev...icated skin and skin structure infections,(cSSSIs... Staphylococcus,aureus (MRSA). , Arpida re...
(Date:11/20/2008)...tCall/ -- Duska Therapeutics,Inc., (OTC Bulletin...ed its,pivotal Phase 3 ATPace clinical trial prot...nt (SPA) procedure with the U.S. Food and Drug Adm...n agreement with the FDA, Duska intends to initiat...ntrolled and randomized Phase 3,clinical trial wi...
(Date:11/20/2008)...PAREXEL International Corporation (Nasdaq: PRXL ...vider, today announced that it has opened an offic...nd clinical research capabilities. With the additi...hroughout five important biopharmaceutical centers...razil, Chile, and Mexico. This expansion further s...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Chemo for Mesothelioma Offers Limited Survival Benefits 19551 1Chemo for Mesothelioma Offers Limited Survival Benefits 19551 2Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 1Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 2Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 3Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 4Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 5Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 6Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 7Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 8Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 9AARP Statement on Governors Bill for Prescription Drug Marketing Reform and Transparency 19547 1AARP Statement on Governors Bill for Prescription Drug Marketing Reform and Transparency 19547 2Senetek PLC Reports First Quarter 2008 Financial Results 5462 1Senetek PLC Reports First Quarter 2008 Financial Results 5462 2Senetek PLC Reports First Quarter 2008 Financial Results 5462 3
...D Are at High,Risk , ,WASHINGTON, March 9, 2007 ...family history of end-stage renal disease (ESRD), ...sk of developing,kidney disease themselves, report...iety of Nephrology. , "A family history of kidney ... are also at substantially higher risk of,ESRD," c...
...07 /PRNewswire-FirstCall/ - Chemokine,Therapeutics... , a,biotechnology company developing chemokine-ba...d vascular disease today announced,positive prelim...se-escalation portion of its Phase Ib/II clinical ...g candidate. No dose,limiting toxicities were obse...
Other Medicine Technology:Nearly 1 in 10 Americans Has A Relative With Kidney Failure 2Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 2Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 3Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 4Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 5
...he Portex® Thermovent® T helps provide pro...patient. It is small and extremely lightweight mak...adults. With a high rate of heat and moisture reco...tion retention., ,All HMEs and filters have ISO s...
...he Portex® Thermovent® T helps provide pro...patient. It is small and extremely lightweight mak...adults. With a high rate of heat and moisture reco...tion retention., ,All HMEs and filters have ISO s...
...even digital models cover the range from 2ul to 50...ume lock design prevents inadvertent volume change...ip. Whole pipette is autoclavable at 121C(250F). ...ropylene. Suitable for one-handed operation. Aut...
...he AlphaPette Pipettor is the #1 Pipettor for sub-...comfort, and reliability. Continuously adjustable....dout sub-micrometer. Easy interchangeable ejector ...le rapid pipet tip ejector with three different le...
Medicine Products: